Linagliptin: Is a dipeptidyl peptidase-4 inhibitor

Linagliptin is a dipeptidyl peptidase-4 inhibitor that increases insulin and decreases glucagon production. It is used with exercise and diet to improve glycemic control in adults with type 2 diabetes, but has some side effects and contraindications. Medscape - Diabetes mellitus type II dosing for Tradjenta ( linagliptin ), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and cost information. Linagliptin is an Antidiabetic Agent belonging to the pharmacological class of Dipeptyl peptidase-4 (DPP-4) inhibitors. Linagliptin is approved for treating type 2 diabetes mellitus. It is used to improve glycemic control by blocking the enzyme DPP-4. It helps to increase levels of incretin hormones ... Linagliptin is used together with proper diet and exercise to treat high blood sugar levels caused by type 2 diabetes mellitus . Linagliptin helps to control blood sugar levels by increasing substances in the body that make the pancreas release more insulin.